Body Weight as a Determining Factor in the Predominance of Adverse Drug Reactions Induced by Fixed-Dose Adalimumab Injections in Female Patients in a Korean Hospital Setting

Adalimumab is used at 40-mg dose to treat systemic inflammatory diseases. Given the impact of adverse drug reactions (ADRs), which particularly result in the discontinuation of adalimumab therapy in female patients, this study examined whether sex affects the frequency and type of ADRs induced by ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kwi Suk, Choi, Young Hee, Moon, Aree, Kim, Sang Geon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074186/
https://www.ncbi.nlm.nih.gov/pubmed/32046138
http://dx.doi.org/10.3390/jcm9020461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074186/
https://www.ncbi.nlm.nih.gov/pubmed/32046138
http://dx.doi.org/10.3390/jcm9020461

Ejemplares similares